NASDAQ$HROW
Harrow Inc · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Reported results for the first quarter 2020.
Harrow Health reported its first quarter 2020 results, with management expressing excitement about the ImprimisRx team's role in providing for physician customers and improving health outcomes as the economy reopens.
- Harrow Health published its first quarter 2020 letter to stockholders.
- CEO Mark L. Baum is excited about the ImprimisRx team getting back to being a trusted provider to physician customers.
- The company is starting to see orders come in as customers re-open.
- Harrow Health is excited about upcoming events, catalysts, and developments in the near and long-term.
Headline financials
Revenue & EPS history
Harrow · Revenue · Quarterly
$11.8M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2020
+1.6%
Avg return
Earnings day
+3.0%
Avg return
5 days after
+8.7%
Avg return
30 days after
52%
25 / 48 earnings
Positive
+49.3%
Q2 2024
Best reaction
-36.0%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -18.5% | — | |
| Q4 2025 | +2.3% | -32.2% | -34.1% | |
| Q3 2025 | +13.6% | +19.5% | +49.7% | |
| Q1 2025 | +3.4% | +6.5% | +25.4% | |
| Q4 2024 | -6.0% | +21.8% | +2.9% | |
| Q3 2024 | -14.1% | -23.9% | -28.9% | |
| Q2 2024 | +49.3% | +56.3% | +67.2% | |
| Q1 2024 | +40.0% | +44.5% | +57.3% | |
| Q4 2023 | +0.3% | +9.6% | +3.4% | |
| Q3 2023 | -36.0% | -30.2% | -21.7% | |
| Q2 2023 | -17.4% | -14.7% | -26.8% | |
| Q1 2023 | -20.5% | -24.1% | -26.9% | |
| Q4 2022 | +6.7% | +22.9% | +42.6% | |
| Q3 2022 | -4.2% | -9.4% | +10.5% | |
| Q2 2022 | +12.2% | +24.6% | +32.6% | |
| Q1 2022 | +3.3% | -5.3% | +15.3% | |
| Q4 2021 | +3.0% | -1.4% | -1.7% | |
| Q3 2021 | -4.9% | -3.3% | -21.1% | |
| Q2 2021 | -0.3% | -0.8% | +13.0% | |
| Q1 2021 | +15.8% | +14.5% | +14.0% | |
| Q4 2020 | +3.5% | +3.4% | -12.3% | |
| Q3 2020 | +25.8% | +30.0% | +19.9% | |
| Q2 2020 | +4.8% | +10.4% | +15.0% | |
| Q1 2020 | -5.8% | -9.7% | +36.5% | |
| Q4 2019 | -7.5% | -16.0% | -3.8% | |
| Q3 2019 | +18.6% | +16.1% | +33.8% | |
| Q2 2019 | -23.6% | -21.7% | -8.0% | |
| Q1 2019 | +10.1% | +16.5% | +26.6% | |
| Q4 2018 | -7.5% | -20.3% | -30.1% | |
| Q3 2018 | +7.2% | +23.0% | +38.4% | |
| Q2 2018 | +13.4% | +29.3% | +26.4% | |
| Q1 2018 | +9.3% | +5.3% | +6.2% | |
| Q4 2017 | -3.4% | -5.3% | -3.9% | |
| Q3 2017 | +5.7% | +19.1% | +7.6% | |
| Q2 2017 | -7.9% | -9.7% | -28.2% | |
| Q1 2017 | -4.8% | -12.6% | -22.5% | |
| Q4 2016 | +2.9% | +17.0% | +79.7% | |
| Q3 2016 | -9.8% | -13.2% | -28.9% | |
| Q2 2016 | -3.1% | -2.6% | +6.5% | |
| Q1 2016 | +1.9% | — | — | |
| Q4 2015 | -2.2% | — | — | |
| Q3 2015 | -6.2% | — | — | |
| Q2 2015 | -1.3% | — | — | |
| Q1 2015 | +1.3% | — | — | |
| Q4 2014 | +3.5% | — | — | |
| Q3 2014 | -2.7% | — | — | |
| Q2 2014 | +7.8% | — | — | |
| Q2 2010 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro